ArticleJournal of family medicine and primary care2025
Prevalence, severity, and association of serum follicle-stimulating hormone level with vasomotor and genitourinary symptoms in perimenopausal and postmenopausal women.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Is Follicle-Stimulating Hormone (FSH) Misnamed? Rethinking Its Role in Menopause as a Systemic Regulator of Bone, Brain, Metabolism, and Aging.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The changes associated with menopause can affect a woman's quality of life. About 50%-80% of women complain of menopausal symptoms such as vasomotor symptoms and genitourinary symptoms. Aims and Objectives: To investigate the prevalence, severity, and association of serum follicle-stimulating hormone (s.FSH) levels with vasomotor and genitourinary symptoms in perimenopausal and postmenopausal women. Materials and Methods: It was a cross-sectional study conducted to assess the severity of the menopausal symptoms using the Menopause Rating Scale, which categorized symptoms on a five-point scale ranging from "none" (0) to "very severe." The correlation of s.FSH with prevalence of genitourinary symptoms was calculated. Results: 144 women were included in the study, out of which 63 (43.75%) belonged to the perimenopausal group and 81 (56.25%) belonged to the menopausal group. The mean age of the study population was 47.03 ± 7.13 years. In the perimenopausal women group, out of 63 women, 54 (85.71%) had joint pain and muscular discomfort, whereas 80 (98.76%) of the menopausal women experienced joint pain. 25 (39.68%) of perimenopausal women had mild vasomotor symptoms. The majority of menopausal women had more severe vasomotor symptoms as compared to premenopausal women. In the perimenopausal women, out of 63, 40 (77.08%) of the women experienced bladder problems, whereas in the menopausal females, a higher percentage, 71 (87.65%) experienced bladder problems. In contrast with the perimenopausal females, the majority of menopausal women had more severe urogenital symptoms. Mild mental exhaustion was reported by 27 (42.85%) perimenopausal women and 45 (55.56%) menopausal women. The majority of women in both groups had minimal symptoms. A significant positive correlation was observed between the severity of vasomotor symptoms and mean s.FSH. Conclusion: The higher prevalence of severe vasomotor, genitourinary, and psychological symptoms in menopausal women compared to perimenopausal women, as observed in our study, is a common trend in the literature. This trend highlights the progressive nature of menopausal symptoms, emphasizing the need for timely and effective management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.